Free Trial

Natural Alternatives International (NAII) Competitors

Natural Alternatives International logo
$4.12 -0.03 (-0.84%)
As of 02/21/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NAII vs. CLYM, ZURA, ANIX, CRDL, XBIT, MGX, ELUT, ALTS, ORMP, and MNOV

Should you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Climb Bio (CLYM), Zura Bio (ZURA), Anixa Biosciences (ANIX), Cardiol Therapeutics (CRDL), XBiotech (XBIT), Metagenomi (MGX), Elutia (ELUT), Janone (ALTS), Oramed Pharmaceuticals (ORMP), and MediciNova (MNOV). These companies are all part of the "pharmaceutical products" industry.

Natural Alternatives International vs.

Climb Bio (NASDAQ:CLYM) and Natural Alternatives International (NASDAQ:NAII) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, community ranking, valuation and media sentiment.

Natural Alternatives International has higher revenue and earnings than Climb Bio. Natural Alternatives International is trading at a lower price-to-earnings ratio than Climb Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Climb BioN/AN/A-$35.12M-$2.13-0.70
Natural Alternatives International$113.80M0.23-$7.22M-$1.29-3.26

Natural Alternatives International received 265 more outperform votes than Climb Bio when rated by MarketBeat users. However, 100.00% of users gave Climb Bio an outperform vote while only 76.29% of users gave Natural Alternatives International an outperform vote.

CompanyUnderperformOutperform
Climb BioOutperform Votes
2
100.00%
Underperform Votes
No Votes
Natural Alternatives InternationalOutperform Votes
267
76.29%
Underperform Votes
83
23.71%

Climb Bio has a beta of -0.24, indicating that its share price is 124% less volatile than the S&P 500. Comparatively, Natural Alternatives International has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500.

69.8% of Climb Bio shares are owned by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are owned by institutional investors. 3.2% of Climb Bio shares are owned by insiders. Comparatively, 20.9% of Natural Alternatives International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Natural Alternatives International had 1 more articles in the media than Climb Bio. MarketBeat recorded 1 mentions for Natural Alternatives International and 0 mentions for Climb Bio. Climb Bio's average media sentiment score of 0.00 equaled Natural Alternatives International'saverage media sentiment score.

Company Overall Sentiment
Climb Bio Neutral
Natural Alternatives International Neutral

Climb Bio presently has a consensus target price of $10.00, indicating a potential upside of 568.90%. Given Climb Bio's stronger consensus rating and higher possible upside, research analysts plainly believe Climb Bio is more favorable than Natural Alternatives International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Climb Bio
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50
Natural Alternatives International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Climb Bio has a net margin of 0.00% compared to Natural Alternatives International's net margin of -6.26%. Natural Alternatives International's return on equity of -9.36% beat Climb Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Climb BioN/A -42.21% -41.39%
Natural Alternatives International -6.26%-9.36%-4.82%

Summary

Natural Alternatives International beats Climb Bio on 9 of the 17 factors compared between the two stocks.

Get Natural Alternatives International News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAII vs. The Competition

MetricNatural Alternatives InternationalMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$25.73M$1.16B$5.84B$9.14B
Dividend YieldN/AN/A4.75%3.86%
P/E Ratio-3.2635.7826.7719.18
Price / Sales0.235.72435.4570.78
Price / CashN/A10.4038.0134.83
Price / Book0.331.927.644.62
Net Income-$7.22M-$53.22M$3.19B$246.06M
7 Day Performance1.45%-5.53%-2.12%-2.63%
1 Month Performance-0.47%-1.92%-0.45%-2.15%
1 Year Performance-31.43%-13.79%16.26%12.88%

Natural Alternatives International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAII
Natural Alternatives International
0.3762 of 5 stars
$4.21
+1.4%
N/A-30.4%$25.73M$113.80M-3.26290Earnings Report
Analyst Forecast
CLYM
Climb Bio
2.4956 of 5 stars
$1.52
-4.4%
$10.00
+557.9%
N/A$102.17MN/A-0.719
ZURA
Zura Bio
2.8396 of 5 stars
$1.55
+3.3%
$15.80
+919.4%
-62.0%$101.20MN/A0.003Gap Up
ANIX
Anixa Biosciences
2.9956 of 5 stars
$3.14
-0.3%
$8.50
+170.7%
-18.3%$101.11M$210,000.00-8.055Analyst Forecast
Analyst Revision
News Coverage
CRDL
Cardiol Therapeutics
2.8824 of 5 stars
$1.22
-1.6%
$8.40
+588.5%
-18.4%$100.78MN/A-3.1320News Coverage
XBIT
XBiotech
0.5161 of 5 stars
$3.27
+1.9%
N/A-56.7%$99.67M$4.01M-3.03100
MGX
Metagenomi
1.8766 of 5 stars
$2.61
+6.5%
$16.67
+538.6%
-79.1%$97.67M$44.76M0.00236News Coverage
ELUT
Elutia
3.6048 of 5 stars
$2.82
-1.4%
$10.00
+254.6%
-13.0%$97.46M$24.75M-1.08180News Coverage
Gap Up
ALTS
Janone
N/A$6.90
+10.6%
N/AN/A$97.08M$39.61M0.00170News Coverage
ORMP
Oramed Pharmaceuticals
1.4757 of 5 stars
$2.40
-2.0%
N/A-33.0%$96.74M$1.34M21.8210Analyst Downgrade
MNOV
MediciNova
2.4398 of 5 stars
$1.97
+5.3%
$9.00
+356.9%
+35.6%$96.63M$1M-9.3810Earnings Report
Analyst Forecast
News Coverage
High Trading Volume

Related Companies and Tools


This page (NASDAQ:NAII) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners